dc.contributor.author | Eraksoy, M. | |
dc.contributor.author | Mutlu, M. | |
dc.contributor.author | Akman-Demir, G. | |
dc.date.accessioned | 2021-03-05T16:14:48Z | |
dc.date.available | 2021-03-05T16:14:48Z | |
dc.identifier.citation | Eraksoy M., Mutlu M., Akman-Demir G., "Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a hospital-based cohort at a university faculty of medicine, multiple sclerosis unit, Istanbul", 19th Meeting of the European-Neurological-Society, Milan, İtalya, 20 - 24 Haziran 2009, cilt.256 | |
dc.identifier.other | av_bfacecd1-5ae6-4f1e-82eb-ad92d56601fb | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/127255 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Nöroloji | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.title | Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a hospital-based cohort at a university faculty of medicine, multiple sclerosis unit, Istanbul | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 256 | |
dc.contributor.firstauthorID | 135907 | |